Medicare GLP-1 Bridge sets a $50 copay from 1 July 2026
Event date 1 Jul 2026 source CMS
We track prices, terms and availability. We are not clinicians, this page is not medically reviewed, and nothing here is medical advice. Talk to a licensed clinician about whether a GLP-1 medication is right for you.
What changed
CMS opened the Medicare GLP-1 Bridge demonstration on 1 July 2026, fixing the beneficiary copay at $50 a month for covered GLP-1 prescriptions through 31 December 2027.
Source: CMS (opens in a new tab)
What it means
For a beneficiary who qualifies, this is the lowest figure on our Wegovy cost page. It also has an end date: the program runs to 31 December 2027. CMS names BALANCE in Part D only as a potential next step, so what follows is not yet settled.
Who qualifies, which drugs are covered and how approval works are on our Medicare GLP-1 Bridge pages, each rule cited to the CMS document it comes from. The cash prices the $50 compares with are on our Wegovy cost guide.